Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TTLL6 is a polyglutamylase enzyme that adds glutamate chains to tubulin and non-tubulin proteins, influencing microtubule dynamics and ciliary function. It is involved in the regulation of microtubule severing and plays a role in the formation and movement of cilia. Additionally, TTLL6 modifies the CGAS protein, affecting immune responses to viral infections. It is associated with several diseases involving cilial dysfunctions and is a potential target for therapeutic interventions related to microtubule regulation and ciliary pathologies.
Polyglutamylation of tubulin and non-tubulin proteins; Regulation of microtubule functions; Stimulation of spastin-mediated microtubule severing
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tubulin tyrosine ligase-like 6 (TTLL6).